Salute e Benessere

InDex Pharmaceuticals announces expected cash balance per March 31, 2024

InDex Pharmaceuticals is currently looking at alternatives for the company's future. The company's cash and cash equivalents as of December 31, 2023, amounts to SEK 294 million. InDex Pharmaceuticals is currently looking at alternatives for the company's future. The company's cash and cash equivalents as ofDecember 31, 2023, amounts toSEK 294 million. The concluding results from the terminated Induction Study 1 of the phase III program CONCLUDE are expected in the latter part of...
PR Newswire
19/01/2024

Coloplast A/S - Q1 2023/24 Earnings Release - Invitation for conference call on…

Friday, 9 February 2024 at 11.00 - 12.00 CETIn connection with the publication of Coloplast's interim financial results for Q1 2023/24, to be released same day around 07.30 am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast's website approximately 1 hour before the conference call. The webcast of the conference call will be available during and after the...
Nasdaq GlobeNewswire
19/01/2024

Affidea Group appoints Frans van Houten, Former CEO of Philips, as a new…

Frans van Houten stated: "Affidea stands as a fast-growth European healthcare champion renowned for its innovative spirit—a spirit I am thrilled to support. The company's longstanding dedication to enhancing every aspect of the care pathway and improving patient outcomes through technological innovation resonates with my own. My commitment is to the seamless integration of cutting-edge, patient-centric solutions that promise quality, personalised and efficient healthcare experiences…
PR Newswire
19/01/2024

LG OPENS NEW SCROLL COMPRESSOR PRODUCTION LINE IN MEXICO

LG's decision to establish a production line in Mexico comes at a time when many U.S. HVAC manufacturers are facing challenges due to escalating logistical disruptions. The strategic move places an LG scroll compressor production base in close proximity to key North American markets; setting up a production/logistics system that will help the company better respond to regional demand and lessen the impact on customers of factors such as logistic issues. LG's decision to establish a production...
PR Newswire
19/01/2024

Cresemba® sales in Latin America trigger first sales milestone payment to…

Allschwil, Switzerland, January 19, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the sales of the antifungal Cresemba ®(isavuconazole) in 2023 by its partner Knight Therapeutics Inc. (“Knight”, TSX: GUD) in Latin America exceeded the threshold triggering the first sales milestone payment for this region.David Veitch, Chief...
Nasdaq GlobeNewswire
19/01/2024

Chairman Jia Shaoqian at Davos 2024: Hisense Remains Focused on Globalization…

Hisense reported double-digit growth in both revenue and profits for 2023, with increases significantly in China as well as various international markets. Hisense reported double-digit growth in both revenue and profits for 2023, with increases significantly inChinaas well as various international markets. The home appliance industry is highly competitive on a global scale. It relies heavily on an integrated system encompassing R&D, manufacturing, marketing, and supply chains...
PR Newswire
19/01/2024

Analyze the Clinical Trial Landscape Through the Pharma Competitive Intelligence…

Our CI Monitoring of R&D assets allows for the tracking of progress, including shifts in developmental phases, patient recruitment and retention, adverse events, and data quality, while tracking intelligence around regulatory and commercial milestones keeps clients abreast of any major market dynamic shift in their vertical. Thus, our service enables companies to detect potential issues early and implement corrective measures. Our CI Monitoring of R&D assets allows for the tracking of...
PR Newswire
18/01/2024

Alpha-1 Antitrypsin Deficiency Market to Register Incremental Growth by 2032…

Key Takeaways from the Alpha-1 Antitrypsin Deficiency Market Report Key Takeaways from the Alpha-1 Antitrypsin Deficiency Market Report Discover which therapies are expected to grab the major AATD market share @Alpha-1 Antitrypsin Deficiency Market Report Alpha-1 Antitrypsin Deficiency Overview Alpha-1 Antitrypsin Deficiency (AATD) is a hereditary autosomal codominant genetic disorder characterized by a shortage of the alpha-1 antitrypsin protein (AAT). This protein is...
PR Newswire
18/01/2024

Natura &Co announces intention to end secondary listing on NYSE

In line with the company's long-term strategic objectives of simplifying operations, Natura &Co has decided to discontinue its secondary listing on the NYSE, as the vast majority of Natura &Co trading activity is concentrated on the B3 stock exchange. The decreasing trading volume of Natura &Co ADRs on the NYSE no longer makes maintaining the listing a compelling option. In line with the company's long-term strategic objectives of simplifying operations, Natura &Co has decided…
PR Newswire
18/01/2024

PHAXIAM Therapeutics announces its cash position at the end of 2023 and its…

Lyon (France) and Cambridge (MA, US), January 18, 2024, at 10:05pm CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections,today announces its cash position as of December 31, 2023, and its financial calendar for 2024.Cash position as of December 31, 2023As of December 31, 2023, PHAXIAM Therapeutics had cash and cash equivalents totaling €10.5 million (approximately $11...
Nasdaq GlobeNewswire
18/01/2024

Hair Transplant Market Size to Grow USD 4136.6 Million by 2029 at a CAGR of 3.6%…

Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-21E6056/Global_Hair_Transplant_Market Claim Your Free Sample Now:https://reports.valuates.com/request/sample/QYRE-Auto-21E6056/Global_Hair_Transplant_Market Major Driving the Growth of Hair Transplant Market The hair transplant industry is expanding rapidly due to a number of factors, including changing beauty standards, technological advancements in hair restoration techniques like FUT and FUE, the...
PR Newswire
18/01/2024

Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus…

Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS) Equal Partnership with AFT Pharmaceuticals for Development of a Drug Releasing Mucoadhesive Film for VLS (HY-091)Limited Availability of Approved Treatment Options in VLSLiège, Belgium – 18 January 2024, 07:00 PM CET – Regulated information – Inside information -Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through...
Nasdaq GlobeNewswire
18/01/2024

The Next Wave of Biological Indicator Vials are Set to Transform Sterilization…

Request Exclusive Sample Report: Biological Indicator Vials Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-6240 Request Exclusive Sample Report: Biological Indicator VialsIndustry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-6240 Biological indicator vials are in high demand, which emphasizes their critical function as test devices containing live bacteria that have a known resistance to...
PR Newswire
18/01/2024

The Evolution of Li-ion Batteries Uplifting the Adoption of Cordless Power…

Browse in-depth TOC on "Cordless Power Tools Market" Browse in-depth TOC on "Cordless Power Tools Market" 572 – Pages 515 - Tables 209- Figures Cordless Power Tools Market Report Scope DIY has seen enormous growth in the past decade. With the trend being popular only in Western countries, it is being rapidly adopted in APAC andLatin America. Most major players, such as Bosch, develop user-friendly tools with NanoBlade technology for DIY enthusiasts...
PR Newswire
18/01/2024

Oncology Precision Medicine Market Size to Hit USD 364 Billion by 2035 | Roots…

Global Oncology Precision Medicine Market Overview Global Oncology Precision Medicine Market Overview The global oncology precision medicine market is growing exponentially; it is estimated to be worthUSD 130 billionin 2023 and is anticipated to reachUSD 364 billionby 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 8.93% during the forecast period from 2023 to 2035. Precision medicine in oncology refers to the study of utilizing an individual's...
PR Newswire
18/01/2024

Healthcare Simulation Market Worth $5.2 Billion | MarketsandMarkets™

Browse in-depth TOC on "Healthcare Simulation Market" Browse in-depth TOC on "Healthcare Simulation Market" 217 - Tables 41 - Figures 305 - Pages Healthcare Simulation Market Scope: "The largest share in the healthcare simulation market, based on product & service, was attributed to the medical simulation anatomical models' segment." The medical simulation anatomical models segment holds the largest market share in the healthcare simulation market. The growth...
PR Newswire
18/01/2024

More Than 350 Companies Increase Efficiency and Compliance with Veeva Training…

"Veeva is helping us streamline GxP training to speed employee qualification and onboarding as we grow," said Debra Sawyer, vice president of quality assurance at PepGen. "Implementing Veeva Vault Training and Veeva LearnGxP improved our efficiency and fostered a more engaging training environment, supporting our commitment to quality excellence and compliance." "Veeva is helping us streamline GxP training to speed employee qualification and onboarding as we grow,"…
PR Newswire
18/01/2024

PureIMS gears up for abbreviated registration of Levodopa Cyclops® DPI against…

In addition to the ideal PK performance, Levodopa Cyclops® has unrivaled ease of use in that it requires only two easy steps before use and does not need to be cleaned. This drastically improves its usability over other products for the intended, motorically impaired patient population. Pharmacodynamics of Levodopa Cyclops® were demonstrated in a phase II study in PD patients experiencing OFF episodes. A significant and clinically meaningful improvement of MDS-UPDRS-part III motor scores was…
PR Newswire
18/01/2024

Hovione certified as a Top Employer in all of its manufacturing sites

This marks a significant milestone in the company's commitment to fostering a supportive workplace environment and providing meaningful and rewarding roles for its team members. It also demonstrates that "One Hovione", a company´s strategic initiative to give team members an equally high-quality experience across all locations, is delivering. The certification program by the Top Employers Institute evaluates organizations through their participation in and outcomes of the HR Best...
PR Newswire
18/01/2024

WELLS ABBOTT TRANSFORMS THE SHOWROOM EXPERIENCE WITH AN INNOVATIVE DESIGN…

"We are rewriting the traditional showroom visit script by having designers engage directly with our English makers in their creative spaces," said Lauren Hudson, President and CEO of The Wells Companies. "We are thrilled to have such a tremendous response from our American designers. Following my first trip to London in 2016 I was inspired to open a to-the-trade showroom with a decidedly British sensibility. Eight years and three showroom locations later, I am honored to launch…
PR Newswire
18/01/2024

Synendos Therapeutics AG Granted EMA Clinical Trial Authorisation for…

Synendos is developing selective endocannabinoid reuptake inhibitors (SERIs) that influence the balance of the ECS in a novel mode of action. The ECS is a key neuromodulator system in the CNS which plays a significant role in how the body responds to stress. By rebalancing and restoring endogenous cannabinoid levels that are dysregulated in certain pathological conditions, this new mode of action has the potential to rebalance brain function in a holistic and pro-homeostatic way to treat…
PR Newswire
18/01/2024

PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient…

The trials are taking place at City of Hope, one of the largest cancer research and treatment organizations in the United States, which also developed the therapy. The trials are taking place atCity of Hope, one of the largest cancer research and treatment organizations inthe United States, which also developed the therapy. During the first month of treatment, the patient only experienced low grade treatment emergent toxicities, including grade 1 cytokine release syndrome ("CRS")...
PR Newswire
18/01/2024

ONWARD® Announces Start of HemON NL Clinical Study

HemON NL is evaluating the use of ARC-IM® Therapy to address hemodynamic instability after spinal cord injury In late 2023, a study participant was implanted with an investigational ARC-IM Neurostimulator and Lead to assess the safety and effectiveness of ARC-IM Therapy to address hemodynamic instability after SCI. The surgery was performed by neurosurgeon Erkan Kurt, MD at Radboud University Medical Center, which has a neurosurgery department affiliated with Sint Maartenskliniek...
Nasdaq GlobeNewswire
18/01/2024

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a…

theJournal of the American Medical Association( JAMA ). NEOTORCH is a randomized, double-blind, placebo-controlled phase 3 trial evaluating the efficacy and safety of toripalimab in combination with perioperative platinum-based chemotherapy vs chemotherapy alone in patients with resectable stage II or III NSCLC. NEOTORCH is the world's first phase III clinical study of a anti-PD-1 monoclonal antibody for NSCLC perioperative treatment (including neoadjuvant and adjuvant) with positive...
Nasdaq GlobeNewswire
18/01/2024
Altri  Comunicati